Site icon AIT365

Axtria Releases Annual Alignment Design and Refinement Benchmarking Study for the Life Sciences Industry

Axtria

Axtria Inc., a global leader in award-winning cloud software and data analytics in the life sciences industry, released findings from its annual alignment design and refinement benchmarking study for life sciences organizations.

The healthcare landscape is evolving at a transformational pace. Rapid market changes often impact sales portfolios, causing disruptions in workload and prioritization. The traditional way of aligning sales teams is no longer effective. To remain competitive, organizations must deploy sophisticated go-to-market models where talent structures are aligned to engage new stakeholders across multiple channels, regions, specialties, and organization sizes. Realigning sales territories at regular intervals is essential to creating balanced workloads and positively impacts the performance of sales reps.

“It is critical to regularly reevaluate and adapt territory alignment processes to account for changes in business dynamics and growth. The impact of inefficient territory alignment is significant,” said Asheesh Sharma, Head of Axtria’s Commercial Excellence Practice. “The right territory design ensures a fair distribution of high-potential targets and maximizes sales opportunities even with a leaner sales force. Sales and commercial operations can benefit from analyzing data acquired through the lenses of therapeutic areas, lifecycle, and rep roles.”

Also Read: Amplity Health’s Breakthrough AI-driven Platform Offers Pharma Leaders Actionable Intel During Crucial Drug Launch Window

Below is a sample of insights from Axtria’s study, which looks at industry trends and best practices in territory design and alignment:

Alignment Design and Refinement Benchmarking Study Highlights:

The Alignment Design and Refinement Benchmarking Study is now available for demonstration and discussion.

Axtria is a global provider of award-winning cloud software and data analytics to the life sciences industry. Axtria’s solutions are used to digitally transform the entire product commercialization process, supporting RWE/HEOR, medical affairs, pricing and market access, product launch and post-launch, and marketing and sales operations to drive growth and improve healthcare outcomes for patients. Our focus is on delivering solutions that help pharmaceutical, medical device, and diagnostics companies complete the journey from data to insights to action and get superior returns from their investments. As a participant of the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption and taking actions that advance societal goals.

SOURCE: PRNewswire

Exit mobile version